Travere Therapeutics, Inc. (TVTX)

27.23 -0.95 (-3.37%) USD  |  NASDAQ  |  Mar 05, 15:02
More

Travere Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for TVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Revolution Medicines, Inc. --
ICU Medical, Inc. Upgrade
Intuitive Surgical, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
iRhythm Holdings, Inc. Upgrade